During the past decade, POLIKUM Institut GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "POLIKUM Institut GmbH" #1 collaborator was "Analyze & Realize" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "POLIKUM Institut GmbH" are "Common Cold" (2 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "POLIKUM Institut GmbH" in a lesser frequency.

Most popular intervention types in "POLIKUM Institut GmbH" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ColdZyme" (2 trials), "ColdZyme Placebo" (1 trials), "Placebo" (1 trials) and "bococizumab (PF-04950615)" (1 trials). Other intervention names were less common.

The vast majority of trials in "POLIKUM Institut GmbH" are 3 trials for "All" genders.

Currently, there are NaN active trials in "POLIKUM Institut GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in POLIKUM Institut GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in POLIKUM Institut GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".